IBM is stopping development and sales of its tool that utilizes Watson AI to help pharmaceutical companies find new drugs, according to a STAT report. A source told STAT that the product, Watson for ...

On Thursday, STAT published a story claiming that IBM is halting sales of Watson for Drug Discovery — a service that uses the company’s Watson AI to analyze connections between genes, drugs, and ...

IBM is ending new sales its Watson programs aimed at artificial intelligence-based drug discovery and development due to poor financial returns, according to a report from Stat. The news follows Big ...

Responding to reports that it will no longer sell its Watson artificial intelligence system for use in drug discovery, IBM says it is “not discontinuing our Watson for Drug Discovery offering” and ...

Improved cognitive computing by the supercomputer has accelerated the pace of scientific breakthroughs by discovering previously unknown connections in Big Data. Available now as a cloud service, ...

IBM has discontinued the development and sales of its Watson for Drug Discovery product due to poor financial performance, according to STAT. This usage of IBM’s Watson artificial intelligence ...

As the AI hype-cycle has built, we've been treated to a plethora of claims about what sorts of improvements and breakthroughs the technology can deliver. One of the most fundamental -- and potentially ...

IBM has announced significant advances in its artificially intelligent computer system, Watson's, cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific ...

As the AI hype-cycle has built, we've been treated to a plethora of claims about what sorts of improvements and breakthroughs the technology can deliver. One of the most fundamental -- and potentially ...